Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Non-cash Items (2016 - 2017)

Corcept Therapeutics' Non-cash Items history spans 2 years, with the latest figure at $263.1 million for Q4 2017.

  • For Q4 2017, Non-cash Items rose 2412.93% year-over-year to $263.1 million; the TTM value through Dec 2017 reached $263.1 million, up 2412.93%, while the annual FY2017 figure was $263.1 million, 2412.93% up from the prior year.
  • Non-cash Items for Q4 2017 was $263.1 million at Corcept Therapeutics, up from $10.5 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $263.1 million in Q4 2017 and bottomed at $10.5 million in Q4 2016.